Skip to main content
. 2022 Nov 14;58(11):1647. doi: 10.3390/medicina58111647

Table 1.

Baseline patients’ characteristics.

Variable Total (n = 163) PT-GBD (n = 33) EUS-GBD
(n = 21)
LC
(n = 81)
OC
(n = 25)
p Value
Age
Median (IQR)
77 (71–82) 83 (75–87) 84 (81–89) 74 (70–79) 74 (69–80) <0.001
Male
No (%)
90 (56%) 12 (36%) 10 (48%) 51 (63%) 17 (68%) 0.03
BMI
Median (IQR)
26.2 (24.2–29.1) 26.7 (23.6–29.6) 25.8 (21.6–28) 25.8 (24.3–25.8) 27.3 (25.2–31.2) 0.24
Clinical Fraility Scale Score (median [range]) 3.00 [1.00, 8.00] 6.00 [2.00, 8.00] 4.00 [2.00, 8.00] 3.00 [1.00, 8.00] 3.00 [2.00, 7.00] <0.001
ACS score
Median (IQR)
6.45
(3.88–17.02)
17.6 (16.4,23) 6.1 (5.3–7.3) 4 (2.8–6) 17.5 (12.9–20.6) <0.001
Non operative management (NOM) failure 36 (22.5) 17 (51.5) 4 (19.0) 11 (13.6) 4 (16.0) <0.001
Previous AC
No (%)
41 (26%) 12 (38%) 8 (38%) 17 (21%) 4 (16%) 0.10
Previous ERCP
No (%)
17 (11%) 3 (9%) 6 (29%) 7 (9%) 1 (4%) 0.12
Anticoagulant therapy
No (%)
47 (29%) 10 (30%) 12 (57%) 18 (22%) 7 (28%) 0.02
WBC
No (×1000)
12 (8.5–16.5) 6.9 (0.7–16.1) 14.7 (7.5–17.1) 12.6 (10.4–17) 11.7 (10.7–14.4) 0.02
Hb [g/dl]
Median (IQR)
12.9 (10.3–13.4) NR NR 13.1 (10.3–14.2) 12.4 (11–14.3) 0.11
CRP [mg/dl]
Median (IQR)
11.5 (4–22.7) 15 (11.2–24) 6.15 (1.87–25) 8.32 (2.4–19.1) 13.5 (7.16–24.8) 0.04
Total Bilirubin [mg/dl]
Median (IQR)
1.2 (0.73–2) 1.2 (0.7–2.4) 1.1 (0.62–1.53) 1.32 (0.88–2.08) 0.9 (0.68–1.87) 0.43
INR
Median (IQR)
1.21 (1.1–1.37) 1.32 (1.21–1.69) 1.23 (1.1–1.36) 1.15 (1.07–1.31) 1.2 (1.13–1.29) 0.008

Continuous variables were reported as median values and interquartile range. Comparisons were performed with ANOVA for continuous variables and chi square test for categorical ones. Significances were reported in bold. Previous AC: previous episode of acute cholecystitis; ERCP: Endoscopic retrograde cholangiopancreatography; WBC: white blood cells; Hb: Hemoglobin; CPR: c-reactive protein; INR: International Normalized Ratio. Bold values are statistically significant.